The long term goal is to compare nociceptive processing by excitatory amino acids (EAAs) and substance P (SP) in the spinal cord. The proposed experiments will test the hypothesis that EAAs & SP in the spinal cord are contained in and released from distinct groups of primary afferents, cause distinct nociceptive characteristics which are inhibited by compounds acting at unique receptor subtypes. Sp.
Aim 1. Anatomical double labeling procedures will be utilized to determine whether anterogradely labeled primary afferent terminal contain glutamate (glu)- like immunoreactivity, whether these terminal are surrounded by astrocytic processes containing glu dehydrogenase or glutamine synthetase, and whether glu immunoreactive fibers and terminal co-contain CGRP or SP. Sp.
Aim 2. We will use in vivo microdialysis in the spinal cords of conscious, freely moving rats to study the release of presumably nociceptive [EEA & SP] and antinociceptive [5HT & NE] transmitters released in response to formalin-injection and in response to specific opioid receptor activity. We will then administer fluorogold, a retrograde tracer, directly into the cannula for combined retrograde tracing-immunocytochemical procedures to identify neurons that may contribute to release. Sp.
Aim 3. Microdialysis will be used in anesthetized rats to compare release of EAAs & SP after electrical stimulation of primary afferents at intensities that activate large and large plus small diameter fibers. Sp.
Aim 4. Using in vivo microdialysis in spinal cords of freely moving animals together with pharmacologic manipulation of NE, 5HT, SP and EAA activity, we will determine whether EAAs & SP differentially activate distinct descending pathways and whether activity at specific monoamine receptor subtypes differentially alters SP or EAA release. Sp.
Aim 5. We will measure autonomic and nociceptive responses in acute and chronic models of allodynia to examine the involvement of EAAs, SP and glycine (gly) in this model of pain. We will compare transmitter release in rats with allodynia to release after formalin-injection (Aim 2). Sp.
Aim 6. EAAs, gly & strychnine will be iontophoresed onto antidromically identified nociceptive dorsal horn neurons and determine the effect of gly on NMDA- and SP-induced depolarization in control rats and in formalin & allodynia-models of chronic pain to determine whether gly potentiates NMDA in nociceptive pathways and whether the interaction between gly & NMDA is different in these 2 models of chronic pain.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
2R01DA004090-04
Application #
3209166
Study Section
Pharmacology I Research Subcommittee (DABR)
Project Start
1986-04-01
Project End
1992-03-31
Budget Start
1989-05-01
Budget End
1990-03-31
Support Year
4
Fiscal Year
1989
Total Cost
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Type
Schools of Veterinary Medicine
DUNS #
168559177
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Larson, A A; Kovacs, K J; Cooper, J C et al. (2000) Transient changes in the synthesis of nitric oxide result in long-term as well as short-term changes in acetic acid-induced writhing in mice. Pain 86:103-11
Larson, A A; Giovengo, S L; Russell, I J et al. (2000) Changes in the concentrations of amino acids in the cerebrospinal fluid that correlate with pain in patients with fibromyalgia: implications for nitric oxide pathways. Pain 87:201-11
Larson, A A; Kovacs, K J; Spartz, A K (2000) Intrathecal Zn2+ attenuates morphine antinociception and the development of acute tolerance. Eur J Pharmacol 407:267-72
Larson, A A; Giovengo, S L; Shi, Q et al. (2000) Zinc in the extracellular area of the central nervous system is necessary for the development of kainic acid-induced persistent hyperalgesia in mice. Pain 86:177-84
Velazquez, R A; Cai, Y; Shi, Q et al. (1999) The distribution of zinc selenite and expression of metallothionein-III mRNA in the spinal cord and dorsal root ganglia of the rat suggest a role for zinc in sensory transmission. J Neurosci 19:2288-300
Li, J; Simone, D A; Larson, A A (1999) Windup leads to characteristics of central sensitization. Pain 79:75-82
Giovengo, S L; Russell, I J; Larson, A A (1999) Increased concentrations of nerve growth factor in cerebrospinal fluid of patients with fibromyalgia. J Rheumatol 26:1564-9
Larson, A A; Kitto, K F (1999) Chelation of zinc in the extracellular area of the spinal cord, using ethylenediaminetetraacetic acid disodium-calcium salt or dipicolinic acid, inhibits the antinociceptive effect of capsaicin in adult mice. J Pharmacol Exp Ther 288:759-65
Giovengo, S L; Kitto, K F; Kurtz, H J et al. (1999) Parenterally administered kainic acid induces a persistent hyperalgesia in the mouse and rat. Pain 83:347-58
Kovacs, K J; Larson, A A (1998) Up-regulation of [3H]DTG but not [3H](+)-pentazocine labeled sigma sites in mouse spinal cord by chronic morphine treatment. Eur J Pharmacol 350:47-52

Showing the most recent 10 out of 84 publications